Paper42004665
The use of a biocompatible carbon fiber implant for cervical and lumbar spine fusion in the treatment of spondylodiscitis: a case report.
Aftab N and 4 others. J Surg Case Rep, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The use of a biocompatible carbon fiber implant for cervical and lumbar spine fusion in the treatment of spondylodiscitis: a case report. Papers, record 42004665. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42004665
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The use of a biocompatible carbon fiber implant for cervical and lumbar spine fusion in the treatment of spondylodiscitis: a case report.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36793045 | Early fusion outcome after surgical treatment of single-level and multi-level pyogenic spondylodiscitis: experience at a level 1 center for spinal surgery-a single center cohort study. | J Orthop Surg Res | 2023 | https://conductscience.org/library/papers/36793045 | PubMed |
| 2 | 33905911 | The Surgical Treatment of Pyogenic Spondylodiscitis using Carbon-Fiber-Reinforced Polyether Ether Ketone Implants: Personal Experience of a Series of 81 Consecutive Patients. | World Neurosurg | 2021 | https://conductscience.org/library/papers/33905911 | PubMed |
| 3 | 33510239 | Carbon-fiber reinforced PEEK instrumentation for spondylodiscitis: a single center experience on safety and efficacy. | Sci Rep | 2021 | https://conductscience.org/library/papers/33510239 | PubMed |
| 4 | 37382293 | Carbon fiber-reinforced PEEK spinal implants for primary and metastatic spine tumors: a systematic review on implant complications and radiotherapy benefits. | J Neurosurg Spine | 2023 | https://conductscience.org/library/papers/37382293 | PubMed |
| 5 | 37730826 | Conservative versus early surgical treatment in the management of pyogenic spondylodiscitis: a systematic review and meta-analysis. | Sci Rep | 2023 | https://conductscience.org/library/papers/37730826 | PubMed |
| 6 | 29321098 | Spondylodiscitis: Diagnosis and Treatment Options. | Dtsch Arztebl Int | 2017 | https://conductscience.org/library/papers/29321098 | PubMed |
| 7 | 38555491 | Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future Applications. | Med Sci Monit | 2024 | https://conductscience.org/library/papers/38555491 | PubMed |
| 8 | 37923678 | Spondylodiscitis instrumented fusion, a prospective case series on a standardized neurosurgical protocol with long term follow up. | Injury | 2024 | https://conductscience.org/library/papers/37923678 | PubMed |
| 9 | 39199573 | A Multidisciplinary Update on Treatment Modalities for Metastatic Spinal Tumors with a Surgical Emphasis: A Literature Review and Evaluation of the Role of Artificial Intelligence. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39199573 | PubMed |
| 10 | 36078889 | Carbon Fiber Implants in Orthopaedic Oncology. | J Clin Med | 2022 | https://conductscience.org/library/papers/36078889 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42004665
GET https://conductscience.org/api/papers/v1/42004665/authors